Chronic lymphocytic leukemia natural history, complications and prognosis: Difference between revisions
Line 9: | Line 9: | ||
===Natural History=== | ===Natural History=== | ||
* Most patients with [[chronic lymphocytic leukemia]] are initially asymptomatic. | |||
* If left untreated, patients with [[chronic lymphocytic leukemia]] may progress to develop wieght, fever, and lymph node swelling. | |||
===Complications=== | ===Complications=== |
Revision as of 01:57, 14 October 2015
Chronic lymphocytic leukemia Microchapters |
Differentiating Chronic lymphocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Chronic lymphocytic leukemia natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Chronic lymphocytic leukemia natural history, complications and prognosis |
FDA on Chronic lymphocytic leukemia natural history, complications and prognosis |
CDC on Chronic lymphocytic leukemia natural history, complications and prognosis |
Chronic lymphocytic leukemia natural history, complications and prognosis in the news |
Blogs on Chronic lymphocytic leukemia natural history, complications and prognosis |
Directions to Hospitals Treating Chronic lymphocytic leukemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
Natural History, Complications and Prognosis
Natural History
- Most patients with chronic lymphocytic leukemia are initially asymptomatic.
- If left untreated, patients with chronic lymphocytic leukemia may progress to develop wieght, fever, and lymph node swelling.
Complications
- Common complications of chronic lymphocytic leukemia include:[1]
Prognosis
- Prognosis is generally good, and the 5-year survival rate of patients with chronic lymphocytic leukemia is approximately 81.7%.[2]
- Common prognostic factors for meningioma chronic lymphocytic leukemia patients age, tumor stage, and the presence of certain genetic mutations.
- The table below lists prognostic factors for chronic lymphocytic leukemia:[3][4]
Prognostic Factor | Description |
---|---|
Age |
|
Gender |
|
Performance status |
|
Stage |
|
Lymphocyte doubling time |
|
Genetic mutations |
|
Prolymphocytes percent |
|
Histological analysis |
|
Lactate dehydrogenase (LDH) level |
|
β2-microglobulin level |
|
Lymphocyte surface marker |
|
Immunoglobulin (Ig)VH gene |
|
Membrane-bound proteins |
|
References
- ↑ Chronic Lymphocytic Leukimea. Wikipedia (2015) https://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia Accessed on October ,12 2015
- ↑ SEER Stat Fact Sheets: Chronic Lymphocytic Leukemia. National Cancer Institute (2015) http://seer.cancer.gov/statfacts/html/clyl.html Accessed on October, 12 2015
- ↑ Nabhan C, Rosen ST (2014). "Chronic lymphocytic leukemia: a clinical review". JAMA. 312 (21): 2265–76. doi:10.1001/jama.2014.14553. PMID 25461996.
- ↑ Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011